These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23803693)

  • 21. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.
    Pathi S; Jutooru I; Chadalapaka G; Nair V; Lee SO; Safe S
    PLoS One; 2012; 7(10):e48208. PubMed ID: 23110215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib Targets Sp Transcription Factors in Cancer Cells.
    Karki K; Harishchandra S; Safe S
    Mol Pharmacol; 2018 Oct; 94(4):1187-1196. PubMed ID: 30115673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
    Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
    Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer.
    Safe S; Shrestha R; Mohankumar K; Howard M; Hedrick E; Abdelrahim M
    World J Gastroenterol; 2021 Oct; 27(38):6387-6398. PubMed ID: 34720529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin decreases specificity protein expression in bladder cancer cells.
    Chadalapaka G; Jutooru I; Chintharlapalli S; Papineni S; Smith R; Li X; Safe S
    Cancer Res; 2008 Jul; 68(13):5345-54. PubMed ID: 18593936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
    Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
    Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity Proteins (Sp) and Cancer.
    Safe S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development.
    Safe S; Abbruzzese J; Abdelrahim M; Hedrick E
    Cancer Prev Res (Phila); 2018 Jul; 11(7):371-382. PubMed ID: 29545399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
    Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
    Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.
    Chadalapaka G; Jutooru I; Burghardt R; Safe S
    Mol Cancer Res; 2010 May; 8(5):739-50. PubMed ID: 20407012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
    Abdelrahim M; Baker CH; Abbruzzese JL; Sheikh-Hamad D; Liu S; Cho SD; Yoon K; Safe S
    Cancer Res; 2007 Apr; 67(7):3286-94. PubMed ID: 17409437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G; Jutooru I; Safe S
    Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
    Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
    Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
    Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
    Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
    Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.
    Abdelrahim M; Smith R; Burghardt R; Safe S
    Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
    Papineni S; Chintharlapalli S; Abdelrahim M; Lee SO; Burghardt R; Abudayyeh A; Baker C; Herrera L; Safe S
    Carcinogenesis; 2009 Jul; 30(7):1193-201. PubMed ID: 19406933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.